Solvac S.A. is a Belgian holding company primarily engaged in managing significant long-term strategic equity investments, notably a majority stake of approximately 30.8% in Solvay S.A., a global leader in advanced materials and specialty chemicals, and a substantial stake in Syensqo S.A., which also operates in specialty chemicals. Founded in 1983 and headquartered in Brussels, Solvac does not directly manufacture products but derives its core business from its portfolio holdings in manufacturing and marketing of specialty polymers, composite materials, soda ash, peroxides, silica, coatings, plastics, chemicals, and pharmaceutical products through these subsidiaries. The company's mission centers on supporting the sustainable growth and value creation of these invested entities, which serve end markets including automotive, aerospace, electronics, medical devices, and energy sectors worldwide. Recent developments include Solvac's ongoing role as a stable reference shareholder, facilitating strategic initiatives and growth in its portfolio companies, with no recent reports of new product launches directly by Solvac but significant shareholder activity and dividend announcements reflecting its financial health and strategic positioning as an investment vehicle in advanced materials and chemical industries. Solvac operates mainly in Belgium but its investment reach and market influence are global through its holdings. The company employs a minimal direct workforce, acting as a financial and strategic holding entity rather than an operational manufacturer. This structure positions Solvac as a key investor and stabilizing force within the specialty chemicals and advanced materials sectors, focusing on shareholder returns through its controlling interests and strategic oversight of its portfolio companies' innovation and expansion efforts.